Literature DB >> 16122849

Immunogenicity and efficacy of three recombinant subunit Pasteurella multocida toxin vaccines against progressive atrophic rhinitis in pigs.

Chih-Ming Liao1, Chienjin Huang, Shih-Ling Hsuan, Zeng-Weng Chen, Wei-Cheng Lee, Cheng-I Liu, James R Winton, Maw-Sheng Chien.   

Abstract

Three short fragments of recombinant subunit Pasteurella multocida toxin (rsPMT) were constructed for evaluation as candidate vaccines against progressive atrophic rhinitis (PAR) of swine. PMT-specific antibody secreting cells and evidence of cellular immunity were detected in rsPMT-immunized pigs following authentic PMT challenge or homologous antigen booster. Piglets immunized with rsPMT fragments containing either the N-terminal or the C-terminal portions of PMT developed high titers of neutralizing antibodies. Pregnant sows immunized with rsPMT had higher levels of maternal antibodies in their colostrum than did those immunized with a conventional PAR-toxoid vaccine. Offspring from rsPMT vaccinated sows had better survival after challenge with a five-fold lethal dose of authentic PMT and had better growth performance after challenge with a sublethal dose of toxin. Our findings indicate these non-toxic rsPMT proteins are attractive candidates for development of a subunit vaccine against PAR in pigs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16122849     DOI: 10.1016/j.vaccine.2005.07.079

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Protective potential of an attenuated Pasteurella multocida, which expresses only the N-terminal truncated fragment of P. multocida toxin.

Authors:  Jayoung Seo; Semi Lee; Hyoju Pyo; Jaeil Lee; Taejung Kim
Journal:  Can J Vet Res       Date:  2010-01       Impact factor: 1.310

Review 2.  Pasteurella multocida: from zoonosis to cellular microbiology.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

3.  Protective immunity conferred by the C-terminal fragment of recombinant Pasteurella multocida toxin.

Authors:  Jeongmin Lee; Hae-Eun Kang; Hee-Jong Woo
Journal:  Clin Vaccine Immunol       Date:  2012-07-25

4.  Application of intact cell-based NFAT-beta-lactamase reporter assay for Pasteurella multocida toxin-mediated activation of calcium signaling pathway.

Authors:  Shuhong Luo; Mengfei Ho; Brenda A Wilson
Journal:  Toxicon       Date:  2007-11-23       Impact factor: 3.033

5.  Expression of 4 truncated fragments of Pasteurella multocida toxin and their immunogenicity.

Authors:  Jayoung Seo; Hyoju Pyo; Semi Lee; Jaeil Lee; Taejung Kim
Journal:  Can J Vet Res       Date:  2009-07       Impact factor: 1.310

6.  Immunization with Streptococcus suis bacterin plus recombinant Sao protein in sows conveys passive immunity to their piglets.

Authors:  Kai-Jen Hsueh; Li-Ting Cheng; Jai-Wei Lee; Yao-Chi Chung; Wen-Bin Chung; Chun-Yen Chu
Journal:  BMC Vet Res       Date:  2017-01-07       Impact factor: 2.741

7.  Immunoinformatic analysis of the whole proteome for vaccine design: An application to Clostridium perfringens.

Authors:  Luis F Soto; Ana C Romaní; Gabriel Jiménez-Avalos; Yshoner Silva; Carla M Ordinola-Ramirez; Rainer M Lopez Lapa; David Requena
Journal:  Front Immunol       Date:  2022-08-30       Impact factor: 8.786

8.  In silico Analysis of Pasteurella multocida PlpE Protein Epitopes As Novel Subunit Vaccine Candidates.

Authors:  Saied Mostaan; Abbas Ghasemzadeh; Parastoo Ehsani; Soroush Sardari; Mohammad Ali Shokrgozar; Mohsen Abolhassani; Gholamreza Nikbakht Brujeni
Journal:  Iran Biomed J       Date:  2020-01-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.